Return to homepagePandemic Pact

Find potent antiviral drugs against SARS-CoV2 by targeting well identified proteins essential to the viral cycle (DrugDesign_SARS2 project)

  • Funded by Institut Pasteur International Network (IPIN)
  • Total publications:0 publications

Grant number: DrugDesign_SARS2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Institut Pasteur International Network (IPIN)

  • Research Location

    France, Italy

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The DrugDesign_SARS2 project aims to find effective antiviral drugs against SARS-CoV-2 that target proteins essential to the viral cycle. The project brings together the expertise of several laboratories and platforms of the Institut Pasteur International Network (Paris, Lille, Rome). The aim of the study is to examine a large number of compounds as quickly as possible using high throughput screening techniques. In a second round, the objective will be to improve the selected compounds, by chemical processes and using the data obtained by the various laboratories.